Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Harry Werner Kirsch
Age : 55
Public asset : 27,925,753 USD
Country of residence : Unknown
Linked companies : Novartis AG

Biography of Harry Werner Kirsch 
Currently, Harry Werner Kirsch is Chief Financial Officer for Novartis AG. Mr. Kirsch is also on the board of 5 other companies. In the past Mr. Kirsch occupied the position of CFO-Global Pharmaceutical Business at Procter & Gamble Co. Mr. Kirsch received an undergraduate degree from Karlsruher Institut fŘr Technologie.


Current positions of Harry Werner Kirsch 
Holdings of Harry Werner Kirsch 
Harry Werner Kirsch : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/02BILL GATES : Bill Gates' next generation nuclear reactor to be built in Wyoming
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
06/10MARIA MARTINEZ : French Industrial Production Unexpectedly Declined in April
DJ
More news


© 2021 People and Ownership :   
Harry Werner Kirsch : Connections 


Latest news about Harry Werner Kirsch 
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020NOVARTISá : aims to expand Beovu use after safety fears hurt launch
RE
2020NOVARTISá : aims to expand Beovu use after safety fears hurt launch
RE
2019Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker
RE
2019Novartis 2019 growth outlook leaves investors wanting more
RE
More news